Published in Ann Surg Oncol on October 15, 2004
Issues affecting molecular staging in the management of patients with melanoma. J Cell Mol Med (2007) 0.92
Molecular staging of melanoma. Ann Surg Oncol (2004) 0.75
Constitutive activation of NF-kappaB and T-cell leukemia/lymphoma in Notch3 transgenic mice. EMBO J (2000) 2.41
Effect of liposuction on insulin resistance and vascular inflammatory markers in obese women. Br J Plast Surg (2004) 2.31
Tissue expansion in the treatment of pressure ulcers. Plast Reconstr Surg (1991) 2.07
Response to anti-tumour necrosis factor alpha blockade is associated with reduction of carotid intima-media thickness in patients with active rheumatoid arthritis. Rheumatology (Oxford) (2007) 1.89
Involvement of p21ras activation in T cell CD69 expression. Eur J Immunol (1994) 1.85
Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization. Ann Oncol (2010) 1.81
Preconditioning effects of levosimendan in coronary artery bypass grafting--a pilot study. Br J Anaesth (2006) 1.64
Calcium modulation activates Epstein-Barr virus genome in latently infected cells. Science (1986) 1.61
Breast reconstruction with abdominal flaps after abdominoplasties. Plast Reconstr Surg (2001) 1.61
Expression pattern of notch1, 2 and 3 and Jagged1 and 2 in lymphoid and stromal thymus components: distinct ligand-receptor interactions in intrathymic T cell development. Int Immunol (1999) 1.60
From Erasmus to Socrates: should mobility move from students to teachers? Lancet (1996) 1.39
Low brain-derived neurotrophic factor (BDNF) levels in serum of Huntington's disease patients. Am J Med Genet B Neuropsychiatr Genet (2007) 1.35
The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas. Clin Cancer Res (2001) 1.33
Human keratinocyte growth factor activity on proliferation and differentiation of human keratinocytes: differentiation response distinguishes KGF from EGF family. J Cell Physiol (1990) 1.32
Steroid sensitivity of thymocyte subpopulations during intrathymic differentiation. Effects of 17 beta-estradiol and dexamethasone on subsets expressing T cell antigen receptor or IL-2 receptor. J Immunol (1989) 1.23
Continuous in vivo activation and transient hyporesponsiveness to TcR/CD3 triggering of human gut lamina propria lymphocytes. Eur J Immunol (1993) 1.22
The BFRF1 gene of Epstein-Barr virus encodes a novel protein. J Virol (2000) 1.20
Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer. Ann Oncol (2003) 1.20
Dermatofibrosarcoma protuberans: wide local excision vs. Mohs micrographic surgery. Cancer Treat Rev (2008) 1.18
Tissue plasminogen activator controls multiple forms of synaptic plasticity and memory. Eur J Neurosci (2000) 1.18
Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements. J Exp Med (1992) 1.14
Increase of mouse resistance to Candida albicans infection by thymosin alpha 1. Infect Immun (1982) 1.13
Localization of Epstein-Barr virus envelope glycoproteins on the inner nuclear membrane of virus-producing cells. J Virol (1989) 1.11
Skin metastases in lung cancer: analysis of a 10-year experience. Oncol Rep (2001) 1.10
The value of clinical diagnosis of digital glomus tumors. Acta Chir Plast (2008) 1.10
Expression of trKB neurotrophin receptor during T cell development. Role of brain derived neurotrophic factor in immature thymocyte survival. J Immunol (1996) 1.09
Cutting edge: functional role for proline-rich tyrosine kinase 2 in NK cell-mediated natural cytotoxicity. J Immunol (2000) 1.08
Inactivation of the IL-6 gene prevents development of multicentric Castleman's disease in C/EBP beta-deficient mice. J Exp Med (1996) 1.08
Increased metastatic lymph node 64 and CYP17 expression are associated with high stage prostate cancer. J Endocrinol (2007) 1.07
Thoracoscopic thymectomy in autoimmune myasthesia: results of left-sided approach. Ann Thorac Surg (2000) 1.06
Human herpesvirus 6 infection in neoplastic and normal brain tissue. J Med Virol (2001) 1.06
Prognostic value of circulating tumor cells in nonmuscle invasive bladder cancer: a CellSearch analysis. Ann Oncol (2012) 1.05
Ubiquitination and degradation of Syk and ZAP-70 protein tyrosine kinases in human NK cells upon CD16 engagement. Proc Natl Acad Sci U S A (2001) 1.05
Reduction pneumoplasty versus respiratory rehabilitation in severe emphysema: a randomized study. Pulmonary Emphysema Research Group. Ann Thorac Surg (2000) 1.05
Human natural killer cells express VLA-4 and VLA-5, which mediate their adhesion to fibronectin. J Immunol (1991) 1.05
Identification and characterization of the product encoded by ORF69 of Kaposi's sarcoma-associated herpesvirus. J Virol (2008) 1.04
Gastric pathology in patients with common variable immunodeficiency. Gut (1999) 1.04
Human B-cell immune response to the polymorphic epithelial mucin. Cancer Res (1993) 1.03
Cancer stem cells and epithelial-mesenchymal transition: revisiting minimal residual disease. Curr Cancer Drug Targets (2010) 1.03
Selective binding of the epidermal growth factor and its specific effects on the epithelial cells of the cornea. Exp Eye Res (1972) 1.02
Differential regulation of miR-21 and miR-146a by Epstein-Barr virus-encoded EBNA2. Leukemia (2012) 1.02
Transcriptional regulation of the interleukin 2 gene by glucocorticoid hormones. Role of steroid receptor and antigen-responsive 5'-flanking sequences. J Biol Chem (1990) 1.02
RAC1/P38 MAPK signaling pathway controls beta1 integrin-induced interleukin-8 production in human natural killer cells. Immunity (2000) 1.02
Innervated island pedicled anterolateral thigh flap for neo-phallic reconstruction in female-to-male transsexuals. J Plast Reconstr Aesthet Surg (2008) 1.00
Integrin-mediated ras-extracellular regulated kinase (ERK) signaling regulates interferon gamma production in human natural killer cells. J Exp Med (1998) 1.00
Co-localization of multiple ErbB receptors in stratified epithelium of oral squamous cell carcinoma. J Pathol (2001) 1.00
Retinoic acid-induced down-regulation of the interleukin-2 promoter via cis-regulatory sequences containing an octamer motif. Mol Cell Biol (1991) 0.99
Role for the Rac1 exchange factor Vav in the signaling pathways leading to NK cell cytotoxicity. J Immunol (1999) 0.98
Intracellular transport and maturation pathway of human herpesvirus 6. Virology (1999) 0.98
Epstein-Barr virus encoded LMP1 downregulates TCL1 oncogene through miR-29b. Oncogene (2009) 0.98
Up-modulation of the expression of functional keratinocyte growth factor receptors induced by high cell density in the human keratinocyte HaCaT cell line. Cell Growth Differ (2000) 0.98
Proline-rich tyrosine kinase-2 activation by beta 1 integrin fibronectin receptor cross-linking and association with paxillin in human natural killer cells. J Immunol (1997) 0.98
Recommendations for the registration of new chemical entities used in the prevention and treatment of osteoporosis. Calcif Tissue Int (1995) 0.97
Epidermal growth factor, somatostatin, and psoriasis. Lancet (1983) 0.97
CD44 triggering enhances human NK cell cytotoxic functions. J Immunol (1994) 0.97
Prevalence of papillomavirus, Epstein-Barr virus, cytomegalovirus, and herpes simplex virus type 2 in urinary bladder cancer. J Med Virol (1998) 0.96
Alterations of microsatellites in neurofibromas of von Recklinghausen's disease. Cancer Res (1995) 0.96
The mechanism of action of the epidermal growth factor. 3. Stimulation of the uptake of labeled precursors into RNA, DNA and proteins induced by EGF in isolated tumor cells. Hormones (1972) 0.96
Evidence for nuclear internalization of exogenous DNA into mammalian sperm cells. Mol Reprod Dev (1993) 0.96
HSP70 inhibition by 2-phenylethynesulfonamide induces lysosomal cathepsin D release and immunogenic cell death in primary effusion lymphoma. Cell Death Dis (2013) 0.96
CD16-mediated p21ras activation is associated with Shc and p36 tyrosine phosphorylation and their binding with Grb2 in human natural killer cells. J Exp Med (1996) 0.95
Fibroblast growth factor 10 induces proliferation and differentiation of human primary cultured keratinocytes. J Invest Dermatol (2001) 0.95
Transxiphoid bilateral palpation in video-assisted thoracoscopic lung metastasectomy. Arch Surg (2001) 0.95
Epidemiological data on burn injuries in Angola: a retrospective study of 7230 patients. Burns (1995) 0.95
Bcl-2/bax mRNA expression ratio as prognostic factor in low-grade urinary bladder cancer. Int J Cancer (1996) 0.94
Differential expression of granzyme A and granzyme B proteases and their secretion by fresh rat natural killer cells (NK) and lymphokine-activated killer cells with NK phenotype (LAK-NK). Eur J Immunol (1992) 0.93
Candida albicans expresses a fibronectin receptor antigenically related to alpha 5 beta 1 integrin. Microbiology (1994) 0.93
Can down-regulation of UDP-glucuronosyltransferases in the urinary bladder tissue impact the risk of chemical carcinogenesis? Int J Cancer (2001) 0.93
Calmodulin antagonism and growth-inhibiting activity of triphenylethylene antiestrogens in MCF-7 human breast cancer cells. Cancer Res (1986) 0.93
Expression of the HMGI(Y) gene products in human neuroblastic tumours correlates with differentiation status. Br J Cancer (2000) 0.93
High frequency of human papillomavirus detection in urinary bladder cancer. Urol Int (1994) 0.93
Post-transcriptional control of c-myc proto-oncogene expression by glucocorticoid hormones in human T lymphoblastic leukemic cells. Nucleic Acids Res (1990) 0.92
TPA induction of Epstein-Barr virus early antigens in Raji cells is blocked by selective protein kinase-C inhibitors. Int J Cancer (1987) 0.92
Surface distribution and internalization of erbB-2 proteins. Exp Cell Res (1992) 0.92
CD69-triggered ERK activation and functions are negatively regulated by CD94 / NKG2-A inhibitory receptor. Eur J Immunol (2000) 0.92
Dual-specificity phosphatase DUSP6 has tumor-promoting properties in human glioblastomas. Oncogene (2011) 0.92
Expression of Egr-1 correlates with the transformed phenotype and the type of viral latency in EBV genome positive lymphoid cell lines. Oncogene (1996) 0.92
Different types of embolization before surgical excision of haemangiomas of the face. Acta Chir Plast (2003) 0.91
Expression of metabotropic glutamate receptors in murine thymocytes and thymic stromal cells. J Neuroimmunol (2000) 0.91
CD69 is expressed on platelets and mediates platelet activation and aggregation. J Exp Med (1990) 0.91
CD133 and ABCB5 as stem cell markers on sentinel lymph node from melanoma patients. Eur J Surg Oncol (2010) 0.91
Once daily tacrolimus formulation: monitoring of plasma levels, graft function, and cardiovascular risk factors. Transplant Proc (2010) 0.91
Human immunodeficiency virus type-1 tat enhances interleukin-2 promoter activity through synergism with phorbol ester and calcium-mediated activation of the NF-AT cis-regulatory motif. Biochem Biophys Res Commun (1994) 0.90
Immunology of gynecologic neoplasms: analysis of the prognostic significance of the immune status. Curr Cancer Drug Targets (2009) 0.90
The angiosome concept applied to arteriovenous malformations of the head and neck. Plast Reconstr Surg (2001) 0.90
4-Hydroxynonenal, a product of cellular lipid peroxidation, which modulates c-myc and globin gene expression in K562 erythroleukemic cells. Cancer Res (1992) 0.90
Doppler ultrasonographic grading of hepatic vascular malformations in hereditary hemorrhagic telangiectasia -- results of extensive screening. Ultraschall Med (2004) 0.90